Aprea Therapeutics
Biotechnology Research
Doylestown, Pennsylvania, United States
13 employees
APRE
- Employees
- 13
- Contacts
- 2
- Emails
- 2
- Phones
- 1
Aprea Therapeutics Overview
- Headquarters
- Doylestown, Pennsylvania, United States
- Website
- www.aprea.com
- Industry
- Biotechnology Research
- Employees
- 13
- Stock Symbol
- APRE
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About Aprea Therapeutics
Aprea Therapeutics (NASDAQ: APRE) is a clinical-stage biopharmaceutical company focused on precision oncology through synthetic lethality. We exist to ensure that cancer doesn't interrupt life's possibilities and dreams. We do this through our unique approach to synthetic lethality that is revolutionizing the future of cancer treatment.
Aprea Therapeutics Contact Details
- People in AeroLeads
- 4
- With contact data
- 2
- Email contacts
- 2
- 50.0% coverage
- Phone contacts
- 1
- 25.0% coverage
Aprea Therapeutics Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Vladimir Bykov | Associated Professor, Md Phd.full Stack |
View
|
|
| Michael Grissinger | Pharmaceutical Executive and Advisor | Washington Crossing, Pennsylvania, United States |
Email
|
| Brian Wiley | Strategic Advisor | Greater Boston, United States |
Email
Phone
|
| John Hamill | SVP & Chief Financial Officer at Aprea |
View
|
Employees by Management Level
Individual contributor
3 profiles
Executive
1 profile
Compare Similar Companies to Aprea Therapeutics
Anocca
Biotechnology Research
Diamyd Medical
Pharmaceutical Manufacturing
Secura Bio, Inc.
Pharmaceutical Manufacturing
Asgard Therapeutics
Biotechnology Research
Pennsylvania Biotechnology Center
Biotechnology
Klus Pharma Inc.
Pharmaceutical Manufacturing
IVIEW Therapeutics
Pharmaceutical Manufacturing
Hamlet BioPharma
Pharmaceutical Manufacturing
SHANTON PHARMA
Biotechnology Research
Modus Therapeutics Holding AB
Biotechnology Research